0.42
0.42 (0%)
As of Feb 14, 2025
Cel Sci Corp [CVM]
Source:
Company Overview
CEL-SCI Corporation is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system.
| Country | United States |
| Headquarters | vienna, virginia |
| Phone Number | (703) 506-9460 |
| Industry | manufacturing |
| CEO | Geert Kersten |
| Website | www.cel-sci.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-6.9 |
| Net Income | $-7.1 |
| Net Cash | $-0.1 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -26.9% |
| Profit as % of Stockholder Equity | -62.6% |
Management Effectiveness
| Return on Equity | -62.6% |
| Return on Assets | -27.5% |
| Turnover Ratio | |
| EBITA | $-6.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $25.7 |
| Total Liabilities | $14.4 |
| Operating Cash Flow | $-4.1 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $4 |
